Life Sciences
In the sector’s constantly evolving landscape, Life Sciences companies often need to address uncertainties while bringing new discoveries and innovative solutions to life. Deloitte's customised solutions can help clients worldwide uncover their potential and drive progress towards the Future of Health.
Looking ahead: What is the outlook for the Life Sciences in 2026?
The life sciences industry may be increasingly borderless, but confidence does not appear to be. According to Deloitte’s 2026 Life Sciences Outlook Survey, 75% of responding biopharma and medtech executives are confident in their own organizations’ financial outlooks for the coming year. However, only 41% feel optimistic about the health of the global economy. The year ahead may reward organisations that are able to harmonise global momentum with local resilience -balancing bold investments in artificial intelligence and emerging technologies with the pragmatic ability to adapt to regulatory and economic change.
Our thinking
Explore the Life Sciences & Healthcare Industry
